174 related articles for article (PubMed ID: 33136534)
21. Long-term changes of choroidal blood flow velocity in Vogt-Koyanagi-Harada disease.
Abe S; Nakamura T; Okumura E; Oiwake T; Okada AA; Hayashi A
Graefes Arch Clin Exp Ophthalmol; 2022 Jun; 260(6):1933-1939. PubMed ID: 34982220
[TBL] [Abstract][Full Text] [Related]
22. Longitudinal observation of subretinal fibrosis in Vogt-Koyanagi-Harada disease.
Zhao C; Dong F; Gao F; Liu X; Pei M; Jia S; Zhang M
BMC Ophthalmol; 2018 Jan; 18(1):6. PubMed ID: 29334924
[TBL] [Abstract][Full Text] [Related]
23. BACILLARY LAYER DETACHMENT IN ACUTE VOGT-KOYANAGI-HARADA DISEASE: A Novel Swept-Source Optical Coherence Tomography Analysis.
Agarwal A; Freund KB; Kumar A; Aggarwal K; Sharma D; Katoch D; Bansal R; Gupta V;
Retina; 2021 Apr; 41(4):774-783. PubMed ID: 32833410
[TBL] [Abstract][Full Text] [Related]
24. Comparison of Clinical Features and Visual Outcome between Sympathetic Ophthalmia and Vogt-Koyanagi-Harada Disease in Chinese Patients.
Yang P; Liu S; Zhong Z; Du L; Ye Z; Zhou W; Kijlstra A
Ophthalmology; 2019 Sep; 126(9):1297-1305. PubMed ID: 30959067
[TBL] [Abstract][Full Text] [Related]
25. Efficacy and Safety of Adalimumab for Exacerbation or Relapse of Ocular Inflammation in Patients with Vogt-Koyanagi-Harada Disease: A Multicenter Study.
Nakai S; Takeuchi M; Usui Y; Namba K; Suzuki K; Harada Y; Kusuhara S; Kaburaki T; Tanaka R; Takeuchi M; Mizuki N; Nakai K; Goto H; Herbort CP
Ocul Immunol Inflamm; 2024 May; 32(4):367-375. PubMed ID: 35748779
[TBL] [Abstract][Full Text] [Related]
26. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients.
Yang P; Ren Y; Li B; Fang W; Meng Q; Kijlstra A
Ophthalmology; 2007 Mar; 114(3):606-14. PubMed ID: 17123618
[TBL] [Abstract][Full Text] [Related]
27. [Autofluorescence combined with spectral domain optical coherence tomography for diagnosis and follow-up of acute Vogt-Koyanagi-Harada disease].
Tian S; Yao J; Wang J; Zhang J; Zhou A
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Jan; 41(1):135-140. PubMed ID: 33509766
[TBL] [Abstract][Full Text] [Related]
28. Sunset glow fundus in Vogt-Koyanagi-Harada disease with or without chronic ocular inflammation.
Keino H; Goto H; Usui M
Graefes Arch Clin Exp Ophthalmol; 2002 Oct; 240(10):878-82. PubMed ID: 12397437
[TBL] [Abstract][Full Text] [Related]
29. Early post-treatment choroidal thickness to alert sunset glow fundus in patients with Vogt-Koyanagi-Harada disease treated with systemic corticosteroids.
Hirooka K; Saito W; Namba K; Mizuuchi K; Iwata D; Hashimoto Y; Ishida S
PLoS One; 2017; 12(2):e0172612. PubMed ID: 28241069
[TBL] [Abstract][Full Text] [Related]
30. Choroidal thickness in convalescent vogt-koyanagi-harada disease.
Takahashi H; Takase H; Ishizuka A; Miyanaga M; Kawaguchi T; Ohno-Matsui K; Mochizuki M
Retina; 2014 Apr; 34(4):775-80. PubMed ID: 23979311
[TBL] [Abstract][Full Text] [Related]
31. Macular edema in chronic Vogt-Koyanagi-Harada syndrome.
Rutzen AR; Ortega-Larrocea G; Frambach DA; Rao NA
Retina; 1995; 15(6):475-9. PubMed ID: 8747440
[TBL] [Abstract][Full Text] [Related]
32. Changes of choroidal structure after corticosteroid treatment in eyes with Vogt-Koyanagi-Harada disease.
Egawa M; Mitamura Y; Akaiwa K; Semba K; Kinoshita T; Uchino E; Sonoda S; Sakamoto T
Br J Ophthalmol; 2016 Dec; 100(12):1646-1650. PubMed ID: 26906951
[TBL] [Abstract][Full Text] [Related]
33. Decrease of choriocapillary vascular density measured by optical coherence tomography angiography in Vogt-Koyanagi-Harada disease.
Liang A; Jia S; Gao F; Han X; Pei M; Qu Y; Xiao J; Zhao C; Zhang M
Graefes Arch Clin Exp Ophthalmol; 2021 Nov; 259(11):3395-3404. PubMed ID: 34216256
[TBL] [Abstract][Full Text] [Related]
34. Photoreceptor Cell Injury Starts in the Initial Stage of Vogt-Koyanagi-Harada Disease.
Zhu R; Zhang J; Qiao L; Zhang Y; Gu X; Yang L
Ocul Immunol Inflamm; 2018; 26(6):934-942. PubMed ID: 28323511
[TBL] [Abstract][Full Text] [Related]
35. Clinical features and visual outcomes of 111 patients with new-onset acute Vogt-Koyanagi-Harada disease treated with pulse intravenous corticosteroids.
Nakayama M; Keino H; Watanabe T; Okada AA
Br J Ophthalmol; 2019 Feb; 103(2):274-278. PubMed ID: 29666121
[TBL] [Abstract][Full Text] [Related]
36. Ocular Inflammation and Choroidal Thickness after Pars Plana Vitrectomy in Chronic Recurrent Stage of Vogt-Koyanagi-Harada Disease.
Park UC; Yu HG
Ocul Immunol Inflamm; 2021 Feb; 29(2):388-395. PubMed ID: 31671005
[No Abstract] [Full Text] [Related]
37. OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY REVEALS PARADOXICALLY DECREASING CHOROIDAL THICKNESS AND INCREASING BLOOD FLOW IN REMITTING VOGT-KOYANAGI-HARADA SYNDROME.
Fayed AE; Gerges TK
Retina; 2022 Sep; 42(9):1788-1795. PubMed ID: 35552322
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Enhanced Depth Imaging and Swept Source Optical Coherence Tomography in Assessment of Choroidal Thickness in Vogt-Koyanagi-Harada Disease.
Chee SP; Chan SN; Jap A
Ocul Immunol Inflamm; 2017 Aug; 25(4):528-532. PubMed ID: 27070488
[TBL] [Abstract][Full Text] [Related]
39. Relationship between retinal lesions and inward choroidal bulging in Vogt-Koyanagi-Harada disease.
Hosoda Y; Uji A; Hangai M; Morooka S; Nishijima K; Yoshimura N
Am J Ophthalmol; 2014 May; 157(5):1056-63. PubMed ID: 24491415
[TBL] [Abstract][Full Text] [Related]
40. Choroidal and Retinal Anatomical Responses Following Systemic Corticosteroid Therapy in Vogt-Koyanagi-Harada Disease Using Swept-Source Optical Coherence Tomography.
Jaisankar D; Raman R; Sharma HR; Khandelwal N; Bhende M; Agrawal R; Sridharan S; Biswas J
Ocul Immunol Inflamm; 2019; 27(2):235-243. PubMed ID: 28700251
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
